Oxford Biomedica, AstraZeneca enter new deal for Covid-19 vaccine
According to the new deal, AstraZeneca will have access to Covid-19 vaccine manufacturing at Oxford Biomedica’s Oxbox facility.

According to the new deal, AstraZeneca will have access to Covid-19 vaccine manufacturing at Oxford Biomedica’s Oxbox facility.
The filing is based on non-clinical and clinical data for Paxlovid and also comprised data from the Phase II/III EPIC-HR…
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
Seven of the ten hepatitis C therapies analysed were found to suppress the SARS-CoV-2 virus.
Leading mRNA Covid-19 vaccine developers race to get their variant-specific boosters authorized, as newer subvariants start to become dominant.
ByThe vaccine doses for Taiwan would be the first shipment to a nation participating in the COVAX Facility.
The team found that a TDZD compound could hinder the Mpro enzyme, which functions as a molecular scissor for viral…
Thank you for subscribing to Pharmaceutical Technology